CLINICAL TRIALS PROFILE FOR TRIPHASIL-21
✉ Email this page to a colleague
All Clinical Trials for TRIPHASIL-21
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00236795 ↗ | A Study of Efficacy and Safety With the Transdermal Contraceptive System Versus Triphasil. | Completed | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Phase 3 | 1997-01-01 | The purpose of the study was to compare the contraceptive efficacy and safety of the transdermal patch to Triphasil. |
NCT02404038 ↗ | A Study to Evaluate the Acceptability and Preference for Contraceptive Options as Proxy for HIV Prevention Methods | Unknown status | Desmond Tutu HIV Centre | N/A | 2015-07-01 | This study will enrol sexually active, healthy girls aged 16-17 to assess and compare the acceptability and preference for a monthly vaginal ring, bi-monthly injectable contraception or daily dose oral contraception, as proxy for female-controlled ARV-based HIV prevention methods. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for TRIPHASIL-21
Condition Name
Clinical Trial Locations for TRIPHASIL-21
Clinical Trial Progress for TRIPHASIL-21
Clinical Trial Phase
Clinical Trial Sponsors for TRIPHASIL-21
Sponsor Name